Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In India, Roche Diagnostics Grows At Twice The Market Rate, But Public Awareness Still Low

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - Roche Diagnostics India (Pvt) Ltd. Chairman and Managing Director Bhuvnesh Agarwal believes the company has benefited from the unprecedented surge in market growth, but still finds public awareness to be an issue when it comes to the most advanced diagnostics available to patients

You may also be interested in...



Roche Diagnostics Cites Ind-Swift’s “Hunger To Grow” As The Two Team Up To Market Heart Attack Diagnostic In India

Roche Diagnostics chooses Ind-Swift in India as marketing partner for TROP T assay to detect heart attacks.

Novartis Tests Blood In APAC; Goes For Deeper Penetration With NAT Tests

MUMBAI - Novartis Diagnostics dominated a large number of Western markets with its nucleic acid testing assays for donated blood, and now the Novartis unit is aiming to mirror that success in the Asia-Pacific region by aligning with private institutions, collaborating with progressive states in countries like India and working closely with non-governmental organizations

Roche Diagnostics’ Asia Pacific Managing Director Roland Diggelmann On Delivering Personalized Medicine: An Interview With PharmAsia News (Part 1 of 2)

Roche Diagnostics has identified Asia Pacific, including India, as its fastest-growing region, which has been consistently growing at 30 percent for the company. Roland Diggelmann, Managing Director at Roche Diagnostics Asia Pacific, told PharmAsia News' Mumbai bureau that with a slew of product launches the region will continue to play a bigger role in the global plans of the company. Diggelmann, who has several countries like Australia, China, Hong Kong, India, Indonesia, Korea, Malaysia, New Zealand, Pakistan, Philippines, Singapore, Taiwan, Thailand, and Vietnam under his charge, discusses Roche's plans in this interview.

Related Content

UsernamePublicRestriction

Register

SC079134

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel